The first national-level figures show just 38% of nursing home staff members accepted the vaccine in early weeks, the CDC reported Monday.
Author: Karen Weintraub, USA TODAY
‘Game changer’ single-dose vaccine from Johnson & Johnson is safe and 66% effective, company says
The one-dose COVID-19 vaccine from J&J is a game changer because of easier and cheaper distribution. A large study has found it safe and effective.
Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial, also provided a range of immunity against new variants
The Novavax vaccine candidate also appears to have mixed levels of effectiveness against coronavirus variants.
The first 22M Americans have been vaccinated for COVID-19, and initial safety data shows everything is going well, CDC says
Side effects remain a common result of both the Pfizer-BioNTech and Moderna vaccines, with 70% of people who self-reported saying they suffered pain.
Monoclonal antibody treatment by Eli Lilly found to cut risk of serious COVID-19, drugmaker reports
A study of nursing home residents found the monoclonal antibody treatment bamlanivimab cut the risk of COVID-19 by up to 80%, maker Eli Lilly announced.
Moderna needs at least 3,000 adolescent volunteers for its COVID-19 vaccine trial. They’re struggling to find them.
More than 2 million minors were diagnosed with COVID-19 in 2020, and many more probably contracted the disease but were never diagnosed.
Millions of Americans with intellectual disabilities, at ‘particularly high risk’ for COVID-19, are still waiting for vaccinations
The vaccine priority level for people who live in group homes varies by state – even though they are more likely to be exposed to and die from COVID.
New coronavirus variants aren’t cause for alarm yet but mutations could make COVID-19 harder to fight, experts say
The two authorized COVID-19 vaccines and others under development are expected to continue to be effective against the new strains of the coronavirus.
Death of Florida doctor after receiving COVID-19 vaccine under investigation
Pfizer says there is no indication its COVID-19 vaccine is connected to the condition that led to the death of Miami OB-GYN Dr. Gregory Michael.
US gets more help in raging battle against COVID-19 as FDA authorizes Moderna vaccine, the second allowed for emergency use
Moderna’s COVID vaccine, the second cleared for use in the U.S., will be shipped this weekend, with first doses expected to be given Monday.